Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of ADMA BIOLOGICS, INC. from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
ADMA BIOLOGICS, INC. quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 31 Mar 2011 to 31 Dec 2025.
  • ADMA BIOLOGICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 31 Dec 2025 was $61,594,000, a 77% increase year-over-year.
  • ADMA BIOLOGICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 31 Dec 2025 was $182,656,000, a 45% increase year-over-year.
  • ADMA BIOLOGICS, INC. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2025 was $182,656,000, a 45% increase from 2024.
  • ADMA BIOLOGICS, INC. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $125,714,000.
  • ADMA BIOLOGICS, INC. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $28,239,000, a 57% increase from 2022.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

ADMA BIOLOGICS, INC. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $182,656,000 $61,594,000 +$26,881,000 +77% 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $155,775,000 $47,515,000 +$10,766,000 +29% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $145,009,000 $40,097,000 +$4,246,000 +12% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $140,763,000 $33,450,000 +$15,049,000 +82% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $125,714,000 $34,713,000 +$52,357,000 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $73,357,000 $36,749,000 +$34,184,000 +1333% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $39,173,000 $35,851,000 +$42,222,000 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $3,049,000 $18,401,000 +$25,190,000 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $28,239,000 $17,644,000 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $2,565,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $6,371,000 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $6,789,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2017 $21,439,645 $6,536,963 -$1,924,494 -42% 01 Jan 2017 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 $19,515,151 $4,559,108 +$23,545 +0.51% 01 Oct 2016 31 Dec 2016 10-K 24 Feb 2017 2016 FY
Q3 2016 $19,538,696 $4,331,239 +$771,185 +15% 01 Jul 2016 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 $20,309,881 $6,012,335 -$1,333,017 -28% 01 Apr 2016 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 $18,976,864 $4,612,469 -$1,006,934 -28% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q4 2015 $17,969,930 $4,582,653 -$467,572 -11% 01 Oct 2015 31 Dec 2015 10-K 24 Feb 2017 2016 FY
Q3 2015 $17,502,358 $5,102,424 -$1,717,735 -51% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $15,784,623 $4,679,318 -$718,073 -18% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016 2016 Q2
Q1 2015 $15,066,550 $3,605,535 +$2,298,337 +39% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
Q4 2014 $17,364,887 $4,115,081 +$586,127 +12% 01 Oct 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q3 2014 $17,951,014 $3,384,689 -$695,742 -26% 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2015 2015 Q3
Q2 2014 $17,255,272 $3,961,245 +$934,199 +19% 01 Apr 2014 30 Jun 2014 10-Q 11 Aug 2015 2015 Q2
Q1 2014 $18,189,471 $5,903,872 -$2,662,225 -82% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1
Q4 2013 $15,527,246 $4,701,208 -$2,449,671 -109% 01 Oct 2013 31 Dec 2013 10-K 09 Mar 2015 2014 FY
Q3 2013 $13,077,575 $2,688,947 +$556,800 +17% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014 2014 Q3
Q2 2013 $13,634,375 $4,895,444 -$3,688,729 -306% 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014 2014 Q2
Q1 2013 $9,945,646 $3,241,647 -$2,026,718 -167% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 $7,918,928 $2,251,537 -$1,296,751 -136% 01 Oct 2012 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q3 2012 $6,622,177 $3,245,747 -$2,264,670 -231% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $4,357,507 $1,206,715 +$1,180,506 +49% 01 Apr 2012 30 Jun 2012 10-Q 12 Aug 2013 2013 Q2
Q1 2012 $5,538,013 $1,214,929 +$686,212 +36% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q4 2011 $6,224,225 $954,786 01 Oct 2011 31 Dec 2011 10-K 06 Mar 2013 2012 FY
Q3 2011 $981,077 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3
Q2 2011 $2,387,221 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2
Q1 2011 $1,901,141 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1

ADMA BIOLOGICS, INC. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $182,656,000 +$56,942,000 +45% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $125,714,000 +$153,953,000 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $28,239,000 +$37,665,000 +57% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $65,904,000 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2025 2024 FY
2016 $19,515,151 -$1,545,221 -8.6% 01 Jan 2016 31 Dec 2016 10-K 24 Feb 2017 2016 FY
2015 $17,969,930 -$605,043 -3.5% 01 Jan 2015 31 Dec 2015 10-K 24 Feb 2017 2016 FY
2014 $17,364,887 -$1,837,641 -12% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
2013 $15,527,246 -$7,608,318 -96% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2015 2014 FY
2012 $7,918,928 -$1,694,703 -27% 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2014 2013 FY
2011 $6,224,225 01 Jan 2011 31 Dec 2011 10-K 06 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.